Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism

Biblos-e Archivo/Manakin Repository

Files in this item

Thumbnail
Share

Delicious Save this on Delicious

Citations

This item appears in the following Collection(s)